- Home
- QNCX vs CCM Comparison
QNCX vs CCM Comparison
Compare QNCX & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNCX | CCM |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 21.4M |
| IPO Year | 2019 | 2009 |
Fundamental Metrics
Financial Performance| Metric | QNCX | CCM |
|---|---|---|
| Price | $1.04 | $4.76 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 35.9K |
| Earning Date | 04-10-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.88 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $3.18 |
| 52 Week High | $4.55 | $10.77 |
Technical Indicators
Market Signals| Indicator | QNCX | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 46.14 | 46.71 |
| Support Level | $0.79 | $4.48 |
| Resistance Level | $1.45 | $5.41 |
| Average True Range (ATR) | 0.13 | 0.44 |
| MACD | -0.03 | -0.07 |
| Stochastic Oscillator | 44.64 | 14.68 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.